Cigna Group (NYSE:CI – Get Free Report) hit a new 52-week high during trading on Thursday following a better than expected earnings announcement. The company traded as high as $318.05 and last traded at $312.8470, with a volume of 257,944 shares traded. The stock had previously closed at $305.41.
The health services provider reported $7.98 earnings per share for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. Cigna Group’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $7.83 EPS.
Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be given a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 annualized dividend and a yield of 2.0%. Cigna Group’s payout ratio is currently 25.82%.
Key Headlines Impacting Cigna Group
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, above analyst estimates, while revenue rose 6% to $73.7 billion. Cigna Q3 results and outlook
- Positive Sentiment: Cigna raised its 2026 adjusted income-from-operations outlook to at least $30.60 per share, reinforcing confidence in its earnings trajectory. Cigna raises 2026 outlook
- Positive Sentiment: At Investor Day, the company outlined a long-term target of 10%–14% adjusted EPS growth and about $50 billion in cumulative operating cash flow through 2030, alongside a $3 billion modernization and productivity initiative. Cigna Q3 results and outlook
- Negative Sentiment: GAAP net income fell to $1.4 billion from $1.87 billion a year earlier, and GAAP earnings per share declined to $5.47 from $6.98. One estimate cited in the coverage also put revenue below expectations, tempering the upbeat adjusted results. Cigna lifts outlook as revenue climbs
Analyst Upgrades and Downgrades
Several brokerages have commented on CI. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $337.00 price objective on shares of Cigna Group in a research report on Thursday, October 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research report on Thursday, August 27th. Evercore initiated coverage on shares of Cigna Group in a report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target on the stock. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, October 31st. Finally, Guggenheim raised their price objective on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Fourteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $336.40.
Check Out Our Latest Analysis on CI
Insider Buying and Selling
In other Cigna Group news, insider Everett Neville sold 617 shares of the stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.
Hedge Funds Weigh In On Cigna Group
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. lifted its stake in shares of Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the period. GQG Partners LLC purchased a new position in Cigna Group during the second quarter valued at $1,628,918,000. Bank of America Corp DE lifted its position in Cigna Group by 8.8% during the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after buying an additional 256,677 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Cigna Group by 10.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after buying an additional 236,340 shares in the last quarter. Finally, Legal & General Group Plc bought a new stake in shares of Cigna Group during the 2nd quarter valued at $542,779,000. Institutional investors own 86.99% of the company’s stock.
Cigna Group Trading Up 2.8%
The stock’s fifty day moving average price is $285.07 and its 200 day moving average price is $281.91. The stock has a market cap of $82.93 billion, a P/E ratio of 13.00, a PEG ratio of 1.00 and a beta of 0.25. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.
Cigna Group Company Profile
The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.
The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.
Featured Articles
- Five stocks we like better than Cigna Group
- Matador Resources Insider Buying and the Case for a Dividend Stock Rebound
- Datadog’s Post-Earnings Sell-Off: A Buying Opportunity in Plain Sight?
- How Much of Tesla’s Robotaxi Future Is Already Priced In?
- 3 AI Infrastructure Plays Beyond Chipmakers
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
